Epidermal Skin Grafts to Improve Healing In Radiation Wounds

Status Recruiting

Clinical Trial Summary

Patients undergoing radiation for the treatment of malignancies may suffer from side effects to the skin in the form of radiation dermatitis. This can lead to local wound formation with poor healing. Treatment options for the resulting wound can range from watchful waiting to more aggressive debridement and secondary grafting. Epidermal grafting is a technique in which autologous epidermis is used to cover wounds that are larger than the donor site. Previous studies have demonstrated that this is an effective treatment for different wounds and ulcers but its utility has not yet been evaluated for the treatment of radiation induced injuries. The CelluTome Epidermal Grafting System is a semi automated device that allows easy formation of epidermal Blister. Our study will evaluate the efficacy of epidermal grafts collected using the CelluTome device in the treatment of radiation dermatitis.

Clinical Trial Description

Patients participating in this study will undergo the epidermal grafting procedure to a part of their radiation-induced wound. The remaining untreated area will serve as an irradiated control. The donor tissue will be collected from normal skin in the upper thigh area. In addition to their primary screening visit, patients will be followed up closely in a series of 9 study visits. During these sessions, photographs will be taken and patients will be asked to fill out questionnaires. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04560803
Study type	Interventional
Source	Massachusetts General Hospital
Contact	Katie Vogel
Phone	6177242168
Email	kevogel@mgh.harvard.edu
Status	Recruiting
Phase	N/A
Start date	January 19, 2021
Completion date	December 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04059809` - Photobiomodulation for Breast Cancer Radiodermatitis	Phase 2/Phase 3
Not yet recruiting	`NCT06040983` - Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing	N/A
Withdrawn	`NCT05505214` - Topical Steroids & Bacterial Decolonization for Radiation Dermatitis	Phase 2
Withdrawn	`NCT04593914` - A Novel Skin Barrier Protectant for Acute Radiodermatitis	N/A
Completed	`NCT05450848` - StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis	N/A
Active, not recruiting	`NCT05594498` - A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients	N/A
Recruiting	`NCT04110977` - A Reminder App to Reduce Radiation Dermatitis Rates in Patients With Head-and-Neck Cancer	N/A
Recruiting	`NCT06158347` - Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients With Localized Breast Cancer	N/A
Recruiting	`NCT05553392` - StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis	N/A
Active, not recruiting	`NCT04268056` - Characterization of Skin Microbiome Profile and it's Correlation to Radiation Dermatitis
Not yet recruiting	`NCT04888234` - Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis.	Phase 2
Terminated	`NCT01597921` - A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer	N/A
Completed	`NCT00481884` - Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients	Phase 3
Completed	`NCT03494205` - Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis	Phase 2
Completed	`NCT05810194` - Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
Completed	`NCT03941665` - Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients	N/A
Not yet recruiting	`NCT02051907` - Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis	Phase 2
Completed	`NCT02839473` - Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial	Phase 3
Completed	`NCT00573365` - LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis	N/A
Completed	`NCT00876642` - Trial Comparing Best Supportive Care to Aloe Vera Gel	Phase 3